Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00639301 · ClinicalTrials.gov registry record
Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life
A clinical trial of Retinoblastoma, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 473
- Enrollment target
- 1
- Study location
NCT00639301: Active study of Retinoblastoma, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00639301 is a study of Retinoblastoma that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 473 participants, below the 561-participant average among 15 other Retinoblastoma trials with a reported enrollment target (16% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00639301, a study of Retinoblastoma, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 473 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find out about the quality of life and health in a group of adults who had retinoblastoma when they were children. By quality of life, we mean how you are feeling about being satisfied with things in your life, including your physical health, your emotional health, and your ability to carry out daily activities. We hope that this information will help us provide better care to future children with retinoblastoma and better follow-up care for survivors of retinoblastoma.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 473 participants |
| Start Date | 2008-03-11 |
| Est. Completion | 2027-03 |
What the registry record for NCT00639301 still lists
NCT00639301 is an observational study that tracks outcomes without assigning an intervention. The registered 473 participants enrollment target is mid-sized for trials with a published cap, below the 561-participant average among 15 other Retinoblastoma trials with a reported enrollment target (16% lower).
The record links to 1 condition, with Retinoblastoma appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.
NCT00639301 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00639301 about?
NCT00639301 is a clinical study titled "Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life". The purpose of this study is to find out about the quality of life and health in a group of adults who had retinoblastoma when they were children. By quality of life, we mean how you are feeling about being satisfied with things in your life, including your physical health, your emotional health, an...
What is the current status of trial NCT00639301?
This trial is currently active not recruiting. The enrollment target is 473 participants. The study started on 2008-03-11. Estimated completion is 2027-03.
What conditions does trial NCT00639301 study?
This clinical trial studies the following conditions: Retinoblastoma.
What interventions are being tested in trial NCT00639301?
The interventions under investigation include: Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00639301?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00639301 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinoblastoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00639301's enrollment target sits among peer trials
473 4th of 15 higher than 12 of 15 other Retinoblastoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Retinoblastoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
RB Liquid Biopsy Biorepository
RECRUITING
-
GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma
RECRUITING · Phase 1
-
Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.
RECRUITING
-
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
RECRUITING
-
Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients
RECRUITING
-
Retinoblastoma Phase II Expanded Access Clinical Trial
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05624996 · 474 participants · Phase 3
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- NCT06051695 · 474 participants · Phase 1
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- NCT06632977 · 474 participants · Phase 2
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- NCT06375083 · 472 participants · Phase 2
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI